Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes

Biochemical and Biophysical Research Communications

Volumn 409, Issue 3, 2011, Pages 378-384

  Hanagata, Nobutaka ^a,b   Li, Xianglan ^a  

^a NATIONAL INSTITUTE FOR MATERIALS SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

FKBP11; IFITM5; Interferon induced genes; Osteoblasts; Tetraspanins

Indexed keywords

BETA 2 MICROGLOBULIN; BONE MARROW STROMAL CELL ANTIGEN 2; CD81 ANTIGEN; CD9 ANTIGEN; FK506 BINDING PROTEIN 11; INTERFERON INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEAT 3; INTERFERON INDUCIBLE PROTEIN 1; INTERFERON INDUCIBLE TRANSMEMBRANE PROTEIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; PROSTAGLANDIN F2 RECEPTOR NEGATIVE REGULATOR; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL STRAIN 3T3; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ANIMALS; ANTIGENS, CD; BETA 2-MICROGLOBULIN; CARRIER PROTEINS; GENE EXPRESSION REGULATION; GENES, MHC CLASS I; GTP-BINDING PROTEINS; IMMUNE SYSTEM; IMMUNITY; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MULTIPROTEIN COMPLEXES; NIH 3T3 CELLS; OSTEOBLASTS; PROTEINS; TACROLIMUS BINDING PROTEINS;

EID: 80955179560     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.136     Document Type: Article

References (37)

1. Lange U.C., Saitou M., Western P.S., Barton S.C., Surani M.A. The Fragilis interferon-inducible gene family of transmembrane proteins is associated with germ cell specification in mice. BMC Dev. Biol. 2003, 3:1-11.
2. Bradbury L.E., Kansas G.S., Levy S., Evans R.L., Tedder T.F. The CD19/CD21 signal transducing complex of human B lymphocytes induces the target of antiproliferative antibody-1 and Leu-13 molecules. J. Immunol. 1992, 149:2841-2850.
3. Deblandre G.A., Marinx O.P., Evans S.S., Majjaj S., Leo O., Caput D., Huez G.A., Wathelet M.G. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth. J. Biol. Chem. 1995, 270:23860-23866.
4. Evans S.S., Lee D.B., Han T., Tomasi T.B., Evans R.L. Monoclonal antibody to the interferon-inducible protein Leu-13 triggers aggregation and inhibits proliferation of leukemic B cells. Blood 1990, 76:2583-2693.
5. Evans S.S., Colla R.P., Leasure J.A., Lee D.B. IFN-α induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J. Immunol. 1993, 150:736-747.
6. Zucchi I., Prinetti A., Scotti M., Valaperta R., Mento E., Reinbold R., Vezzoni P., Sonnino S., Albertini A., Dulbecco R. Association of rat8 with Fyn protein kinase via lipid rafts is required for rat mammary cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 2004, 101:1880-1885.
7. Saitou M., Barton S.C., Surani M.A. A molecular programme for the specification of germ cell fate in mice. Nature 2002, 418:293-300.
8. Tanaka S.S., Nagamatsu G., Tokitake Y., Kasa M., Tam P.P., Matsui Y. Regulation of expression of mouse interferon-induced transmembrane protein like gene-1, Ifitm3 (mil-1/fragilis), in germ cells. Dev. Dynam. 2004, 230:651-659.
9. Hanagata N., Takemura T., Monkawa A., Ikoma T., Tanaka J. Phenotype and gene expression pattern of osteoblast-like cells cultured on polystyrene and hydroxyapatite with pre-adsorbed type-I collagen. J. Biomed. Mater. Res. Part A 2007, 83:362-371.
10. Hanagata N., Li X., Morita H., Takemura T., Li J., Minowa T. Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J. Bone Miner. Metab. 2011, 29:279-290.
11. Moffatt P., Gaumond M.-H., Salois P., Sellin K., Bessette M.-C., Godin E., de Oliveira P.T., Atkins G.J., Nanci A., Thomas G. Bril: a novel bone-specific modulator of mineralization. J. Bone Miner. Res. 2008, 23:1497-1508.
12. Bradbury L.E., Goldmacher V.S., Tedder T.F. The CD19 signal transduction complex of B lymphocytes. Deletion of the CD19 cytoplasmic domain alters signal transduction but not complex formation with TAPA-1 and Leu 13. J. Immunol. 1993, 151:2915-2927.
13. Frey M., Appenheimer M.M., Evans S.S. Tyrosine kinase- dependent regulation of L-selectin expression through the Leu-13 signal transduction molecule. J. Immunol. 1997, 158:5424-5434.
14. Matsumoto A.K., Martin D.R., Carter R.H., Klickstein L.B., Ahearn J.M., Fearon D.T. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 1993, 178:1407-1417.
15. Sato S., Miller A.S., Howard M.C., Tedder T.F. Regulation of B lymphocyte development and activation by the CD19/CD21/CD81/Leu 13 complex requires the cytoplasmic domain of CD19. J. Immunol. 1997, 159:3278-3287.
16. Calupny N.J., Aruffo A., Esselstyn J.M., Chan P.Y., Bajorath J., Blake J., Gilliland L.K., Ledbetter J.A., Tepper M.A. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur. J. Immunol. 1995, 25:2978-2984.
17. Tuveson D.A., Carter R.H., Soltoff S.P., Fearon D.T. CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. Science 1993, 260:986-989.
18. Uckun F.M., Burkhardt A.L., Jarvis L., Jun X., Stealey B., Dibirdik I., Myers D.E., Tuel-Ahlgren L., Bolen J.B. Signal transduction through the CD19 receptor during discrete developmental stages of human B-cell ontogeny. J. Biol. Chem. 1993, 268:21172-21184.
19. Weng W.K., Jarvis L., LeBien T.W. Signaling through CD19 activates Vav/Mitogen-activated protein kinase pathway and induces formation of a CD19/Vav/Phosphatidylinositol 3-kinase complex in human B cell precursors. J. Biol. Chem. 1994, 269:32514-32521.
20. Rubinstein E., Le Naour F., Lagaudriere-Gesbert C., Billard M., Conjeaud H., Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR, and VLA integrins. Eur. J. Immunol. 1996, 26:2657-2665.
21. Stipp C.S., Orlicky D., Hemler M.E. FPRP a major highly stoichiometric highly specific CD81- and CD9-associated protein. J. Biol. Chem. 2001, 276:4853-4862.
22. Yount J.S., Moltedo B., Yang Y-Y., Charron G., Moran T.M., Lopez C.B., Hang H.C. Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat. Chem. Biol. 2010, 6:610-614.
23. Ishikawa J., Kaisho T., Tomizawa H., Lee B.O., Kobune Y., Inazawa J., Oritani K., Itoh M., Ochi T., Ishihara K., Hirano T. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 1995, 26:527-534.
24. Blasius A.L., Giurisato E., Cella M., Schreiber R.D., Shaw A.S., Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naïve mouse but a promiscuous cell surface antigen following IFN stimulation. J. Immunol. 2006, 177:3260-3265.
25. Taylor G.A., Feng C.G., Sher A. p47 GTPase: regulations of immunity to intracellular pathogens. Nat. Rev. Immunol. 2004, 4:100-109.
26. Santiago H.C., Feng C.G., Bafica A., Roffe E., Arantes R.M., Cheever A., Taylor G., Vierira L.Q., Aliberti J., Gazzinelli R.T., Sher A. Mice deficient in LRG-47 display enhanced susceptibility to Trypanosoma cruzi infection associated with defective hematopoiesis and intracellular control of parasite growth. J. Immunol. 2005, 175:8165-8172.
27. MacMicking J.D., Taylor G.A., McKinney J.D. Immune control of tuberculosis by IFN-γ-inducible LRG-47. Science 2003, 302:654-659.
28. Martens S., Sabel K., Lange R., Uthaiah R., Wolf E., Howard J.C. Mechanisms regulating the positioning of mouse p47 resistance GTPase LRG-47 and IIGP1 on cellular membranes: retargeting to plasma membrane induced by phagocytosis. J. Immunol. 2004, 173:2594-2606.
29. Smith J.B., Herschman H.R. The glucocorticoid attenuated response genes GARG-16, GARG-39, and GARG-49/IRG2 encode inducible proteins containing multiple tetratricopeptide repeat domains. Arch. Biochem. Biophys. 1996, 330:290-300.
30. Kitamura Y., Spleiss O., Li H., Taniguchi T., Kimura H., Nomura Y., Gebicke-Haerter P.J. Lipopolysaccharide-induced switch between retinoid receptor (RXR) alpha and glucocorticoid attenuated response gene (GARG)-16 messenger RNAs in cultured rat microglia. J. Neurosci. Res. 2001, 64:553-563.
31. Orlicky D.J. Negative regulatory activity of a prostaglandin F2 alpha receptor associated protein (FPRP). Prostag. Leukot. Ess. Fatty Acids 1996, 54:247-259.
32. Orlicky D.J., Lieber J.G., Morin C.L., Evans R.M. Synthesis and accumulation of a receptor regulatory protein associated with lipid droplet accumulation in 3T3-L1 cells. J. Lipid Res. 1998, 39:1152-1161.
33. Charrin S., Le Naour F., Oualid M., Billard M., Faure G., Hanash S.M., Boucheix C., Rubinstein E. The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J. Biol. Chem. 2001, 276:14329-14337.
34. Sala-Valdes M., Ursa A., Charrin S., Rubinstein E., Hemler M.E., Sanchez-Madrid F., Yanez-Mo M. EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins. J. Biol. Chem. 2006, 281:19665-19675.
35. Grewal T.S., Genever P.G., Brabbs A.C., Birch M., Skerry T.M. Best5: a novel interferon-inducible gene expressed during bone formation. Faseb J. 2000, 14:523-531.
36. Smith R.A., Young J., Weis J.J., Weis J.H. Expression of the mouse fragilis gene product in immune cells and association with receptor signaling complexes. Genes Immunol. 2006, 7:113-121.
37. Brass A.L., Huang I.-C., Benita Y., John S.P., Krishnan M.N., Feeley E.M., Ryan B.J., Weyer J.L., van der Weyden L., Fikrig E., Adams D.J., Xavier R.J., Farzan M., Elledge S.J. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139:1243-1254.